Cogstate Limited (ASX:CGS)

Market Cap	405.67M +96.6%
Revenue (ttm)	84.06M +18.8%
Net Income	16.16M +46.7%
EPS	0.09 +44.6%
Shares Out	171.17M
PE Ratio	25.74
Forward PE	21.70
Dividend	0.02 (0.91%)
Ex-Dividend Date	n/a

Volume	80,463
Average Volume	321,994
Open	2.370
Previous Close	2.370
Day's Range	2.240 - 2.370
52-Week Range	1.210 - 2.970
Beta	-0.04
RSI	58.77
Earnings Date	Feb 19, 2026

About Cogstate

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophre...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 148
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CGS

Financial Performance

In fiscal year 2025, Cogstate's revenue was $53.09 million, an increase of 22.25% compared to the previous year's $43.43 million. Earnings were $10.14 million, an increase of 86.15%.

Financial numbers in USD